中华全科医师杂志
中華全科醫師雜誌
중화전과의사잡지
CHINESE JOURNAL OF GENERAL PRACTITIONERS
2012年
4期
294-296
,共3页
张笛%赵光斌%李良平%袁素平%张宇妮%何晓娟
張笛%趙光斌%李良平%袁素平%張宇妮%何曉娟
장적%조광빈%리량평%원소평%장우니%하효연
肝病%随访
肝病%隨訪
간병%수방
Liver diseases%Follow-up studies
随机选取我院2010年8月至2011年5月246例门诊慢性肝病患者,调查患者中以病毒性肝炎及肝硬化患者为主(74.0%,182例),其他肝病患者较少.病毒性肝炎及肝硬化患者失访率较低(40.1%,73/182),低于其他肝病失访率(X2=12.382,P<0.05).失访者中,病毒性肝炎及肝硬化患者与其他肝病患者相比性别差异无统计学意义(X2=10.137,P>0.05),不同年龄(X2=31.783,P<0.05)、学历(X2 =32.803,P<0.05)比较,差异均有统计学意义.在失访原因中对于病情的不重视(44例,38.3%)及医生沟通欠佳(21例,18.3%)为主要原因.加强对于慢性肝病患者对疾病认识非常重要.
隨機選取我院2010年8月至2011年5月246例門診慢性肝病患者,調查患者中以病毒性肝炎及肝硬化患者為主(74.0%,182例),其他肝病患者較少.病毒性肝炎及肝硬化患者失訪率較低(40.1%,73/182),低于其他肝病失訪率(X2=12.382,P<0.05).失訪者中,病毒性肝炎及肝硬化患者與其他肝病患者相比性彆差異無統計學意義(X2=10.137,P>0.05),不同年齡(X2=31.783,P<0.05)、學歷(X2 =32.803,P<0.05)比較,差異均有統計學意義.在失訪原因中對于病情的不重視(44例,38.3%)及醫生溝通欠佳(21例,18.3%)為主要原因.加彊對于慢性肝病患者對疾病認識非常重要.
수궤선취아원2010년8월지2011년5월246례문진만성간병환자,조사환자중이병독성간염급간경화환자위주(74.0%,182례),기타간병환자교소.병독성간염급간경화환자실방솔교저(40.1%,73/182),저우기타간병실방솔(X2=12.382,P<0.05).실방자중,병독성간염급간경화환자여기타간병환자상비성별차이무통계학의의(X2=10.137,P>0.05),불동년령(X2=31.783,P<0.05)、학력(X2 =32.803,P<0.05)비교,차이균유통계학의의.재실방원인중대우병정적불중시(44례,38.3%)급의생구통흠가(21례,18.3%)위주요원인.가강대우만성간병환자대질병인식비상중요.
A questionnaire and telephone survey was conducted on 246 patients with chronic liver diseases in the Outpatient Clinic from August 2010 to May 2011.The distribution of diseases and the causes of losing follow-up were analyzed. Most subjects in this survey (182/246,74.0% ) were patients with chronic viral hepatitis( HBV or HCV)and cirrhosis; and their follow-up status was better than others (X2 =12.382,P < 0.05). There were no differences in gender( X2 =10.137,P > 0.05),but significant differences in age ( X2 =31.783,P < 0.05 ) and educational levels ( X2 =32.803,P < 0.05 ) between patients with chronic viral hepatitis and cirrhosis and patients with other liver diseases.The main causes of losing follow-up were neglect of disease by patients (38.3%) and lack of good communication between doctors and patients ( 18.3% ).It is important to reinforce the understanding and awareness of chronic liver diseases for patients.